Pramlintide vs Amylin
Written by Aaron CuhaReviewed Sep 2026
The short answer
The hormone and the drug built to replace it. Natural human amylin clumps together into sticky deposits, which is why it could never be given as a medicine. Pramlintide exists because swapping three of its building blocks stops that from happening.
- Pramlintide people
- 684
- Pramlintide nulls
- 0
- Amylin people
- 651
- Amylin nulls
- 0
Dose
Approved label amounts
15, 30, 45, 60 and 120 mcg
The approved pramlintide amounts, in mcg.
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
2 completed trials, 651 people given it
First-hand reports are counted on each profile and never added together. This page sets two published records side by side. It does not pick a winner.
Column A
PramlintidePramlintide (amylin analogue)
The only amylin drug ever approved for diabetes. The FDA now lists every Symlin product as discontinued. Approved is not the same as available.
Column B
AmylinAmylin (islet amyloid polypeptide)
Amylin is a hormone that comes out of the same pancreas cells as insulin, at the same time. Cagrilintide and CagriSema are built from it. Human amylin clumps into sticky deposits, so it can never be a drug in its own form.
Side by side, on the facts we can check
| What we compare | Pramlintide | Amylin |
|---|---|---|
| Category | Metabolic | Metabolic |
| FDA status | Approved as Symlin. But as of September 2026, the FDA's drug database (Drugs@FDA) lists every Symlin product as discontinued. Approved does not mean still on sale. | Natural amylin is not a drug. Its approved lab-made version, pramlintide (Symlin), is listed as Discontinued in the FDA drug database (Drugs@FDA) as of September 2026. Cagrilintide is investigational, in final-stage studies combined with semaglutide. |
| Half-life | ~48 minutes | Native amylin is short-lived in circulation. For the approved analogue pramlintide the label gives roughly 48 minutes. |
| Molecular weight | 3,949.4 Da | Mature peptide is 37 amino acids, amidated, with one intramolecular disulfide. Precursor 9,806 Da (UniProt P10997). Pramlintide acetate is 3,949.4 Da per its FDA label. |
| How it works | It switches on amylin receptors. That slows how fast the stomach empties, holds back glucagon after meals and helps people feel full. It works alongside insulin. | Amylin has no receptor of its own. It works through the calcitonin receptor paired with one of three helper proteins, which makes three versions of the amylin receptor. Because it borrows the calcitonin receptor, amylin drugs overlap with calcitonin. In the body, amylin slows how fast the stomach empties. It keeps glucagon down after a meal. And it makes you feel full through a spot in the brainstem called the area postrema. |
| Studies in people | 4 | 2 |
| Evidence | Moderate: 3 completed trials, 684 people given it | Moderate: 2 completed trials, 651 people given it |
| Legal status, US | FDA-approved, prescription only | Not a drug; a natural body hormone, given only by drip in research |
Frequently asked questions
What is the difference between Pramlintide and Amylin?
Pramlintide: The only amylin drug ever approved for diabetes. The FDA now lists every Symlin product as discontinued. Approved is not the same as available. Amylin: Amylin is a hormone that comes out of the same pancreas cells as insulin, at the same time. Cagrilintide and CagriSema are built from it. Human amylin clumps into sticky deposits, so it can never be a drug in its own form.
Which has stronger research evidence, Pramlintide or Amylin?
Each compound gets a band worked out from facts we counted, with the math shown. Pramlintide is Moderate (3 completed trials, 684 people given it). Amylin is Moderate (2 completed trials, 651 people given it). That counts how much has been done in people. It does not rate whether either one works, and neither one is called the winner.
Are Pramlintide and Amylin FDA-approved?
Pramlintide: Approved as Symlin. But as of September 2026, the FDA's drug database (Drugs@FDA) lists every Symlin product as discontinued. Approved does not mean still on sale.. Amylin: Natural amylin is not a drug. Its approved lab-made version, pramlintide (Symlin), is listed as Discontinued in the FDA drug database (Drugs@FDA) as of September 2026. Cagrilintide is investigational, in final-stage studies combined with semaglutide..
Related posts
Blog articles that cover Pramlintide or Amylin, newest first.
Reviewed Sep 2026. This page puts two published records side by side. It is for learning, and it is not medical advice. When this site shows a dose, it is the dose a trial or a clinic actually used, or what people say they did, with the source attached. None of it tells you what to take.